GTX Inc. tacks on 4.88% on positive news about its muscle drug Ostarine, while preliminary earnings results send Affymetrix shares down 22%.
3:22PM 10/13/08
Xoma's promising study results on a diabetes drug makes it more likely it will find a partner.
3:14PM 09/12/08
Vivus climbs on interim data for a midstage study on obesity drug Qnexa.
6:22PM 05/23/08
Cramer says the company is well positioned to profit on the rapid growth of wind power.
7:48PM 05/14/08
The biotech rises on a narrowed first-quarter loss.
6:00PM 05/12/08
The crew likes the wrestling promoter's stock.
7:09PM 02/25/08
Shares vault 36% after Acapodene shows success in reducing prostate cancer treatment side effects.
4:22PM 02/25/08
Genentech's new Avastin approval helps lift the biotech sector.
3:35PM 02/25/08
Myriad Genetics and Dendreon are among those with major clinical trials next year.
12:06PM 12/12/07
Sigma Designs and GTX trade lower on negative analyst research.
10:04PM 05/02/07
Our Experts' Take at RealMoney
However, option traders boost January calls.
4:37PM 11/21/08
This market is producing a few stocks that could represent exceptional opportunities.
3:03PM 11/21/08
More Experts' Takes
More popular tickers are indicated by scale.



